Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Enters Osteoarthritis Deal with British Hospital

NEW YORK, Aug 14 – Incyte and the Guy's and St. Thomas' Hospital NHS Trust of London said Tuesday they had agreed to study osteoarthritis, a common arthritic condition that affects more than 21 million Americans.

Under the terms of the deal, Incyte will own the intellectual property stemming from the partnership.

Scientists at Guy's & St. Thomas' and at Incyte's laboratory in Cambridge, UK, said they would conduct a genetics study to elucidate the genetic component of osteoarthritis and to determine the effects particularly to the knee.

Incyte of Palo Alto, Calif., has already identified genes in its database that may have a role in the osteoarthritis, while the British researchers have been gathering data from patients with osteoarthritis of the knee for over 10 years. 

"Osteoarthritis is an important priority area for the development of high value information to aid in the treatment and diagnosis of this debilitating disease," Roy Whitfield, Incyte’s CEO, said in a statement. 

Incyte said it would use the information it gathers through the collaboration to develop new therapeutics and diagnostics for osteoarthritis, which predominantly affects the elderly.

Financial terms of the deal were not disclosed.


The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.